Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Infections News
DAA therapy regardless of SVR reduces hepatic, extrahepatic mortality
Results of a prospective study showed that treatment with direct-acting antivirals for hepatitis C correlated with significantly reduced risks for hepatocellular carcinoma and mortality, according to a study published in The Lancet.
ALT flares in HBV low, linked to seroconversion in untreated patients
Among patients with chronic hepatitis B, the cumulative incidence of severe alanine aminotransferase flares was low and correlated with decreased HBV DNA levels and loss of HBV e-antigen, according to recently published data.
Log in or Sign up for Free to view tailored content for your specialty!
UV devices decontaminate CT tables
Study findings showed that UV devices can capably reduce pathogens on CT patient tables, and researchers said the devices “could provide an effective and efficient adjunct to manual cleaning in radiology procedure rooms.”
Urban clinic sites link more than two-thirds of patients with HCV to care
More than two-thirds of patients with hepatitis C who visited a Federally Qualified Health Center in Philadelphia were linked to care, including both antibody and RNA testing, and many continued to medical evaluation, according to a study published in Hepatology.
Non-characterized nodules linked to early HCC following DAA therapy
Patients undergoing direct-acting antiviral therapy for hepatitis C who had non-characterized liver nodules had a higher risk for hepatocellular carcinoma within a short follow-up time than other patients, according to a recently published study.
Pet hedgehogs cause multistate outbreak of Salmonella
Health officials have linked a multistate outbreak of Salmonella Typhimurium infections to contact with pet hedgehogs, the CDC reported.
Pet hedgehogs cause multistate outbreak of Salmonella
Health officials have linked a multistate outbreak of Salmonella Typhimurium infections to contact with pet hedgehogs, the CDC reported.
Dicerna completes first dosing in phase 1 trial of RNA-based HBV therapy
Dicerna Pharmaceuticals announced the dosing of the first volunteer in a phase 2 clinical trial of DCR-HBVS, the company’s investigational GalXCTM-based therapy for the treatment of chronic hepatitis B, according to a press release.
Lincoln Financial joins American Liver Foundation to raise HCV awareness
Lincoln Financial Group and the American Liver Foundation have joined together to raise awareness of hepatitis C in the U.S. and improve educational resources, according to a press release.
S. stercoralis infection ‘widely prevalent’ in Bolivia
Researchers discovered a wide prevalence of strongyloidiasis — a chronic intestinal infection caused by a soil-transmitted intestinal nematode — among immunocompromised patients in Bolivia.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read